Developer docs
API playgroundTry for free, no card

Search company profiles

modeus

Full company profile

uuid0021mos

Namestring
modeus
Legal namestring
Modeus Pty Ltd
Websiteurl
modeus.com.au
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Modeus Pty Ltd is an Australian-headquartered, privately held healthcare software company founded in 2003 that develops electronic controlled drug register and medication management software for regulated healthcare settings. The company's portfolio spans ten specialized products — DDBook and MethDA Cloud (pharmacy, including methadone administration), DiamondCare (aged care), HS8 (hospital-wide across Pharmacy, Ward, and Theatre), Vet S8 (veterinary), Mine8 (mining and remote sites), Ware S8 (manufacturers, wholesalers, and distributors), Medic8 (ambulance and patient transport), Lifelinx (mobile app for pharmacy groups), mHire (equipment rental management), and Modentity (SSO/identity) — deployed across pharmacy, hospital, aged care, veterinary, mining, ambulance, and warehouse verticals to replace paper-based registers with real-time recording, audit trails, and stock discrepancy alerting.

The platform integrates with major industry software providers, including RxOne, Minfos, and ReCare in pharmacy and RxWorks and ezyvet in veterinary, embedding Modeus within customer workflows. Following formal Medsafe approval of DDBook Cloud in September 2025, the company is expanding in New Zealand via a strategic partnership with ReCare (announced December 2025) and operates dedicated go-to-market presences across APAC, EMEA, and the US, serving more than 5,000 organizations globally. Leadership comprises CEO Carl Zufi.

Modeus generates revenue through subscription and software licensing, priced on a quote-based annual cadence with a sales-led motion (Request a Demo / Get a Quote CTAs). The company is privately held with no disclosed funding rounds, operates with 11–50 employees, and has no reported ownership changes, M&A, or institutional investor backing in the available data.

Short descriptiontext

Modeus is an Australian private healthcare software company founded in 2003 that provides electronic controlled drug register and medication management software across pharmacy, hospital, aged care, veterinary, mining, and ambulance sectors in APAC, EMEA, and the US, serving 5,000+ organizations via subscription licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Product category
Unspecified
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Licensing/Subscription
TypeSubscription Recurring
Description

Modeus generates revenue through software licensing and subscription models for their electronic drug register and medication management products. Products are offered as cloud-based solutions with licensing accounts for customers. The company has been serving the healthcare industry for over 21 years.

modeus.co
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1Enterprise licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Contact for pricing - quote-based sales model

modeus.co
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 11 records shown
1DDBook
Description

Electronic drug register for pharmacy

modeus.co
+10 more records
Core offering1 text field

No substantive source material with verifiable source identifiers (WX-prefixed IDs) was provided in the input to describe Modeus's core offering. Only the company name was supplied.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Real-time alerting enables immediate investigation of stock discrepancies
+3 more records
Product overview1 text field

Modeus offers a comprehensive suite of electronic controlled drug register software for healthcare, spanning multiple clinical settings. The portfolio includes DDBook (electronic drug register for pharmacy, with MethDA/MethDA Cloud for methadone programs), DiamondCare (aged care), HS8 (hospital-wide), VetS8 (veterinary), Mine8 (mining/remote locations), Ware S8 (warehouses/manufacturers/distributors), and Medic8 (ambulance/paramedic services). Additional offerings include Lifelinx (mobile app for pharmacy groups) and mHire (equipment rental management for pharmacies). Modentity provides SSO and identity management across the platform. The company pioneered electronic drug register software in 2003 starting with methadone programs and later launching the world's first drug register software. Products are available across APAC, EMEA, and US regions.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-16
Description

Modeus announced a strategic partnership with New Zealand-based ReCare to integrate its Medsafe-approved DDBook Cloud electronic controlled drug register with ReCare's pharmacy software. The integration makes DDBook Cloud available to all New Zealand pharmacies ahead of December 30 physical audit requirements. This partnership follows successful launch with RxOne and formal Medsafe approval in September 2025, supporting Modeus's rapid market expansion across New Zealand.

2RxOne
Strategic tierCoreTypeTechnology or Integration
Description

RxOne is an integration partner for DDBook Cloud. The partnership followed successful launch and contributed to Modeus's expansion in the New Zealand pharmacy market alongside Medsafe approval.

modeus.co
Strategic tierCoreTypeTechnology or Integration
Description

Minfos is a pharmacy software integration partner referenced in customer testimonials. Customer Paul Clarke from Optimal Pharmacy Plus specifically cited Minfos integration as a key benefit of DDBook.

4RxWorks
Strategic tierCoreTypeTechnology or Integration
Description

RxWorks is a veterinary software integration partner. Dr. Will Gartrell from Frankston Heights Veterinary Centre specifically praised the VetS8 and RxWorks integration as a fantastic system that drastically improved workflow.

modeus.co
Strategic tierCoreTypeTechnology or Integration
Description

ezyvet is a veterinary software brand integrated with Vet S8. PetStock Vets case study highlights successful integration of ezyvet brands into Vet S8 for enhanced inventory management.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Oracle Health (Cerner)
TypeBroad incumbent
Description

Oracle Health (formerly Cerner) provides enterprise EHR and medication management modules for hospitals and health systems, including controlled substance ordering and administration. Represents the broad incumbent risk that could subsume Modeus's HS8 functionality in large hospital deployments.

TypeBroad incumbent
Description

Epic Systems is the dominant US hospital EHR vendor with embedded medication administration, controlled substance ordering, and pharmacy modules. A broad incumbent whose expansion of in-EHR controlled drug features could limit Modeus's hospital expansion runway.

TypeDirect peer
Description

RxNT offers electronic prescribing, EPCS (controlled substance e-prescribing), and pharmacy management software for community pharmacies and providers. Directly comparable to Modeus's DDBook for controlled drug workflow and DEA-compliant e-prescribing in US markets.

TypeDirect peer
Description

Omnicell provides automated medication and controlled substance management solutions for hospitals and health systems, including closed-loop administration and diversion detection. Directly comparable to Modeus's HS8 hospital and MethDA controlled-drug focus, though Omnicell operates at much larger enterprise scale.

5CISA (Controlled Substances Information System) by Murraysmith
TypeRegional player
Description

Murraysmith and similar regional systems integrators deliver controlled substance audit and compliance tooling for US healthcare and pharmacy operators. Represents a regional comparability point for Modeus's controlled drug compliance niche outside the Australian/NZ home market.

TypeDirect peer
Description

ScriptPro builds pharmacy management and automation software including controlled substance tracking for community and hospital pharmacies. A close functional peer to Modeus's DDBook in the community pharmacy controlled drug register niche, particularly in US markets.

TypeDirect peer
Description

Imprivata provides healthcare-focused identity and access management, including SSO, authentication, and clinical workflow security. Comparable to Modeus's Modentity platform and addresses the same healthcare IAM buyer, with much broader scale and a US-led footprint.

TypeDirect peer
Description

PioneerRx is a pharmacy management software platform serving independent and chain community pharmacies with dispensing, clinical, and controlled substance workflow modules. Functionally comparable to Modeus's DDBook in the community pharmacy software layer.

9Swisslog Healthcare
TypeBroad incumbent
Description

Swisslog Healthcare provides hospital pharmacy automation, medication management, and controlled substance tracking solutions for acute and retail pharmacy settings. A broader incumbent with adjacent capabilities to Modeus's HS8 hospital platform.

10Becton Dickinson (BD) - Pyxis
TypeDirect peer
Description

BD's Pyxis MedStation and Pyxis CIISafe lines manage controlled substance dispensing, tracking, and audit trails in hospital and pharmacy settings. Overlaps directly with Modeus's HS8 and DDBook product capabilities and represents the dominant incumbent in automated controlled drug management globally.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

modeus

Unspecifiedmodeus.com.au

Modeus is an Australian private healthcare software company founded in 2003 that provides electronic controlled drug register and medication management software across pharmacy, hospital, aged care, veterinary, mining, and ambulance sectors in APAC, EMEA, and the US, serving 5,000+ organizations via subscription licensing.

What modeus does

Modeus Pty Ltd is an Australian-headquartered, privately held healthcare software company founded in 2003 that develops electronic controlled drug register and medication management software for regulated healthcare settings. The company's portfolio spans ten specialized products — DDBook and MethDA Cloud (pharmacy, including methadone administration), DiamondCare (aged care), HS8 (hospital-wide across Pharmacy, Ward, and Theatre), Vet S8 (veterinary), Mine8 (mining and remote sites), Ware S8 (manufacturers, wholesalers, and distributors), Medic8 (ambulance and patient transport), Lifelinx (mobile app for pharmacy groups), mHire (equipment rental management), and Modentity (SSO/identity) — deployed across pharmacy, hospital, aged care, veterinary, mining, ambulance, and warehouse verticals to replace paper-based registers with real-time recording, audit trails, and stock discrepancy alerting.

The platform integrates with major industry software providers, including RxOne, Minfos, and ReCare in pharmacy and RxWorks and ezyvet in veterinary, embedding Modeus within customer workflows. Following formal Medsafe approval of DDBook Cloud in September 2025, the company is expanding in New Zealand via a strategic partnership with ReCare (announced December 2025) and operates dedicated go-to-market presences across APAC, EMEA, and the US, serving more than 5,000 organizations globally. Leadership comprises CEO Carl Zufi.

Modeus generates revenue through subscription and software licensing, priced on a quote-based annual cadence with a sales-led motion (Request a Demo / Get a Quote CTAs). The company is privately held with no disclosed funding rounds, operates with 11–50 employees, and has no reported ownership changes, M&A, or institutional investor backing in the available data.

modeus firmographics

Firmographics
Name
modeus
Legal name
Modeus Pty Ltd
Website
https://modeus.com.au
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
Modeus is an Australian private healthcare software company founded in 2003 that provides electronic controlled drug register and medication management software across pharmacy, hospital, aged care, veterinary, mining, and ambulance sectors in APAC, EMEA, and the US, serving 5,000+ organizations via subscription licensing.
Ownership category
akta.pro rank

Where modeus is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

modeus business model

Business model
GTM type
B2B
Offering type
Services

Revenue model

  1. Software Licensing/Subscription: Modeus generates revenue through software licensing and subscription models for their electronic drug register and medication management products. Products are offered as cloud-based solutions with licensing accounts for customers. The company has been serving the healthcare industry for over 21 years.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise licensing

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

modeus product offering

Product offering

Core offering

No substantive source material with verifiable source identifiers (WX-prefixed IDs) was provided in the input to describe Modeus's core offering. Only the company name was supplied.

Product overview

Modeus offers a comprehensive suite of electronic controlled drug register software for healthcare, spanning multiple clinical settings. The portfolio includes DDBook (electronic drug register for pharmacy, with MethDA/MethDA Cloud for methadone programs), DiamondCare (aged care), HS8 (hospital-wide), VetS8 (veterinary), Mine8 (mining/remote locations), Ware S8 (warehouses/manufacturers/distributors), and Medic8 (ambulance/paramedic services). Additional offerings include Lifelinx (mobile app for pharmacy groups) and mHire (equipment rental management for pharmacies). Modentity provides SSO and identity management across the platform. The company pioneered electronic drug register software in 2003 starting with methadone programs and later launching the world's first drug register software. Products are available across APAC, EMEA, and US regions.

Differentiator

Problem solved

Functional benefit

Brands

  • DDBook: Electronic drug register for pharmacy
  • DiamondCare
  • HS8
  • Lifelinx
  • Medic8
  • Mine8
  • VetS8
  • WareS8
  • mHire
  • Modentity
  • MethDA

Quantifiable outcome

  • Real-time alerting enables immediate investigation of stock discrepancies
  • +3 more outcomes

Companies that use modeus

Customer profile

Named customers11 records

Segments8 records

modeus technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature10 records

modeus partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • ReCarecoreChannel Partner/ Reseller/ Distributor · 16 December 2025Modeus announced a strategic partnership with New Zealand-based ReCare to integrate its Medsafe-approved DDBook Cloud electronic controlled drug register with ReCare's pharmacy software. The integration makes DDBook Cloud available to all New Zealand pharmacies ahead of December 30 physical audit requirements. This partnership follows successful launch with RxOne and formal Medsafe approval in September 2025, supporting Modeus's rapid market expansion across New Zealand.
  • RxOnecoreTechnology or IntegrationRxOne is an integration partner for DDBook Cloud. The partnership followed successful launch and contributed to Modeus's expansion in the New Zealand pharmacy market alongside Medsafe approval.
  • MinfoscoreTechnology or IntegrationMinfos is a pharmacy software integration partner referenced in customer testimonials. Customer Paul Clarke from Optimal Pharmacy Plus specifically cited Minfos integration as a key benefit of DDBook.
  • RxWorkscoreTechnology or IntegrationRxWorks is a veterinary software integration partner. Dr. Will Gartrell from Frankston Heights Veterinary Centre specifically praised the VetS8 and RxWorks integration as a fantastic system that drastically improved workflow.
  • ezyvetcoreTechnology or Integrationezyvet is a veterinary software brand integrated with Vet S8. PetStock Vets case study highlights successful integration of ezyvet brands into Vet S8 for enhanced inventory management.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

modeus competitors and assessment

Company assessment

Broad incumbents

  • Oracle Health (Cerner): Oracle Health (formerly Cerner) provides enterprise EHR and medication management modules for hospitals and health systems, including controlled substance ordering and administration. Represents the broad incumbent risk that could subsume Modeus's HS8 functionality in large hospital deployments.
  • Epic Systems: Epic Systems is the dominant US hospital EHR vendor with embedded medication administration, controlled substance ordering, and pharmacy modules. A broad incumbent whose expansion of in-EHR controlled drug features could limit Modeus's hospital expansion runway.
  • Swisslog Healthcare: Swisslog Healthcare provides hospital pharmacy automation, medication management, and controlled substance tracking solutions for acute and retail pharmacy settings. A broader incumbent with adjacent capabilities to Modeus's HS8 hospital platform.

Direct peers

  • RxNT: RxNT offers electronic prescribing, EPCS (controlled substance e-prescribing), and pharmacy management software for community pharmacies and providers. Directly comparable to Modeus's DDBook for controlled drug workflow and DEA-compliant e-prescribing in US markets.
  • Omnicell: Omnicell provides automated medication and controlled substance management solutions for hospitals and health systems, including closed-loop administration and diversion detection. Directly comparable to Modeus's HS8 hospital and MethDA controlled-drug focus, though Omnicell operates at much larger enterprise scale.
  • ScriptPro: ScriptPro builds pharmacy management and automation software including controlled substance tracking for community and hospital pharmacies. A close functional peer to Modeus's DDBook in the community pharmacy controlled drug register niche, particularly in US markets.
  • Imprivata: Imprivata provides healthcare-focused identity and access management, including SSO, authentication, and clinical workflow security. Comparable to Modeus's Modentity platform and addresses the same healthcare IAM buyer, with much broader scale and a US-led footprint.
  • PioneerRx: PioneerRx is a pharmacy management software platform serving independent and chain community pharmacies with dispensing, clinical, and controlled substance workflow modules. Functionally comparable to Modeus's DDBook in the community pharmacy software layer.
  • Becton Dickinson (BD) - Pyxis: BD's Pyxis MedStation and Pyxis CIISafe lines manage controlled substance dispensing, tracking, and audit trails in hospital and pharmacy settings. Overlaps directly with Modeus's HS8 and DDBook product capabilities and represents the dominant incumbent in automated controlled drug management globally.

Regional players

  • CISA (Controlled Substances Information System) by Murraysmith: Murraysmith and similar regional systems integrators deliver controlled substance audit and compliance tooling for US healthcare and pharmacy operators. Represents a regional comparability point for Modeus's controlled drug compliance niche outside the Australian/NZ home market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

modeus social profiles

Digital presence

modeus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

modeus leadership team

Management profile

Number of profiles

modeus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

modeus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about modeus

What does modeus do?

No substantive source material with verifiable source identifiers (WX-prefixed IDs) was provided in the input to describe Modeus's core offering. Only the company name was supplied.

Is modeus a public or private company?

modeus is a private company. It is classified as unknown and is currently operating.

When was modeus founded?

modeus was founded in 2003. It employs 11 to 50 people.

Where is modeus based?

modeus is headquartered in Melbourne, Australia, in the Oceania region.

How does modeus make money?

One revenue line is on record: software Licensing/Subscription.

Who are modeus's main competitors?

Broad incumbents on record are Oracle Health (Cerner), Epic Systems and Swisslog Healthcare. Direct peers are RxNT, Omnicell, ScriptPro, Imprivata, PioneerRx and Becton Dickinson (BD) - Pyxis. CISA (Controlled Substances Information System) by Murraysmith is listed as a regional player.

Does modeus have an API?

No public API is recorded for modeus.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmacytodayModeus Expands New Zealand Controlled Medication Management with ReCare PartnershipModeus announced a strategic partnership with New Zealand-based ReCare to integrate its Medsafe-approved DDBook Cloud electronic controlled drug register with ReCare's pharmacy software, making it available to all New Zealand pharmacies ahead of December 30 physical audit requirements. The digital solution replaces paper-based controlled drug registers, providing real-time recording, audit trails, and automatic updates to streamline compliance and improve safety. Following successful launch with RxOne and formal Medsafe approval in September 2025, Modeus is rapidly expanding its market presence across New Zealand through this partnership.EIN PresswireControlled Substance Market to Grow at 7.5% CAGR from 2025-2029The Business Research Company published a market report projecting the controlled substance market to grow from $100.19 billion in 2025 to $133.97 billion in 2029, representing a 7.5% CAGR. Key growth drivers cited include precision medicine, telemedicine, opioid alternatives, and regulatory revisions. A collaboration between UK-based CMM (CareFlow Medicines Management Ltd.) and Australia's Modeus introduced a new controlled drug management platform (CD Manager) for hospital pharmacies.MobiHealthNewsWellSky partners with Modeus for paperless drug administration systemWellSky International partnered with Modeus to launch WellSky CD Manager, a paperless controlled drug administration system for UK and Ireland hospitals. The system integrates with WellSky's existing CD systems and aims to reduce operational costs and improve governance. WellSky plans to extend the platform to sites in the Netherlands, Belgium, Norway, Sweden, and South Africa.